The nucleotide sequence of gene PBI, the putative translational product of which i8 homologous to salivary proline-rich protein P-B, has been determined. PBI is 6.4 kb long and contains 3 exons. PBI appears to code for the precursor of a proline-rich protein which we have designated P-Bl. The P-Bl precursor is composed of 134 amino acid residues including 22 residues of signal sequence, 23 residues of N-terminal sequence, five repeating units of 13 to 14 residues and 22 residues of C-terminal sequence. The signal sequence of this precursor is identical with that of the P-B precursor. The N-terminal 61 residue sequence of P-Bl has homology of 75% with the whole sequence of P-B (57 residues), when deletion of 4 residues is taken into account. P-Bl is 55 residues longer than P-B. The nucleotide sequence data reported in this paper will appear in the DDBJ, EMBL, and GenBank nucleotide sequence databases with the following accession number D89501.
identical with those of P-B, was isolated from bovine developing enamel by Strawich and Glimcher (8) . The apparent molecular weight of this protein is 31,000 as determined by SDS polyacrylamide gel electrophoresis. Since the molecular weight of P-B is 5,793, there could be other P-B like proteins in humans.
Although antibodies against other saliva proteins such as proline-rich protein C (9) and cystatins (20) have been reported, we have not been able to prepare antibodies against P-B in mice, rats, or rabbits. The unavailability of antibodies against P-B has hampered studies on this protein and other antigenically related proteins, if present, in human saliva, as well as studies on species specificity of P-B.
This study was initiated to isolate the P-B gene and other genes belonging to the same family to obtain information on their expression, intron-exon structures and family relationships.
MATERIALS AND METHODS
The following materials were purchased from the sources indicated: A.EMBL3 human genomic library, human submaxillary gland cDNAs, Toyobo; Escherichia coli JM109 competent cells, size markers for electrophoresis, and PCR reagents, Takara Shuzo; dye terminator sequencing kit, Perkin-Elmer; ECL direct nucleic acid labeling system, ECL 3'-oligonucleotide labeling system, and ECL detection system, Amersham; enzymes and reagents used for molecular cloning, Toyobo and Takara Shuzo; custommade oligonucleotides used as probes and primers, Asahi Emerse; DNA extraction kit, Wako Pure Chemicals.
XCharon 35 Human Genome Library-A A Charon 35 library was constructed from a complete HmdIII digest of normal human genomic DNA by the method of Horn (11) .
Probe Preparation-A BamHl/Pstl fragment (418 bp) of P-B cDNA prepared according to the method described previously (7) and a HindSH/EcoBI fragment (598 bp) of B41 (see below) were labeled according to the method described in the protocol of the ECL direct labeling system. Oligonucleotide probes were labeled according to the method described in the protocol of the ECL 3'-oligonucleotide labeling system.
Hybridization and Detection-Hybridization and detection were performed according to the method described in the protocol of the ECL direct nucleic acid or ECL 3'-oligonucleotide labeling system using hybridization reagents contained in the kit.
DNA Sequencing-The nucleotide sequences were determined by a DNA sequencer (Perkin Elmer 373S) using the dye terminator dideoxy method following the protocol of the manufacturer. The determined sequence was confirmed by re-analysis using custom-made primers designed to be hybridizable with the determined sequence. For confirmation of the sequence between the second and third Sacl sites, phage DNA of clone b21 was used as a template instead of the plasmid prepared from the PCR product, to exclude errors due to misamplification by PCR (see below).
DNA Preparation from Human Blood-Human genomic DNA was prepared from human leucocytes according to the protocol of the DNA extraction kit. As for other experimental techniques, standard protocols for molecular finning were employed {12).
Isolation of Genomic Clone B41-B41 was cloned by screening 2.3 X 10" plaques of A Charon 35 human genomic library using the P-B cDNA fragment as a probe as described above. Hybridization was performed by shaking in hybridization buffer containing 0.5 M NaCl at 42"C overnight. Membranes were washed with low stringency buffer [0.5 x SSC (1X SSC is a solution containing 15 mM sodium citrate and 150 mM NaCl), 0.4% SDS and 6M urea] at 42'C. Positive clone B41 was selected for further analysis.
Isolation of Genomic Clone b21-b21 was cloned by screening 4xlO 4 plaques of A.EMBL3 human genomic library using the HindUl/EcoRl B41 fragment as a probe. Conditions of hybridization and membrane washing were the same as in the case of B41 cloning.
Preparation of Plasmids for Sequencing-DNA of B41 was digested by HindlH and the resultant fragment of 20 kbp which was hybridizable with the P-BcDNA BamHl/ Pstl fragment was subcloned into PUC18. DNA of b21 was digested by Sacl and the fragments of 4.6 and 2.6 kbp which were hybridizable with an oligonucleotide corresponding to 13-30 nt and a BamHl/Pstl fragment of P-BcDNA (7), respectively, were subcloned into PUC18. A 900 bp Sacl fragment located between the two Sacl fragments of 4.6 and 2.6 kbp was obtained by Sacl digestion of the PCR product amplified using b21 as a template and subcloned into PUC18. The primers used in PCR are oligonucleotides corresponding to 3637-3657 nt and to the complementary chain of 5218-5237 nt. For the numbering see Fig. 2 .
Homology Search-Computerized homology search was performed by using FASTA search service. 
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RESULTS
Sequence analysis of the plasmid subcloned from genomic clone B41 revealed that the 5'-terminal region of the insert of this plasmid was the 3'-terminal region of a gene closely related to, but not identical with that for proline-rich protein P-B. The upstream sequence of this P-B-related gene was determined by analyzing clone b21. Clone b21 covered the entire P-B related gene termed PBI, the approximate size of which was 6.4 kbp. Restriction maps of PBI and the sequencing strategy are shown in Fig. 1 . The determined nucleotide sequence is shown in Fig. 2 . In the light of the structure of P-B cDNA, this gene was considered to be composed of three exons. The size of the first exon was 88 bp but this value is approximate, since the transcriptional start site was not precisely determined. The putative transcriptional start point was assigned by considering that P-B cDNA has a T-rich region at its 5' terminus (7) and that transcription usually starts at about 20 to 30 bases downstream of a TATA box (13) . The first exon contained a 5'-untranslated region. The second exon was 68 bp long. This exon was composed of 14 bp of 5' non-coding sequence and 54 bp of coding sequence corresponding to 18 amino acid residues of the signal sequence. The third exon was 508 bp long. This value is also approximate, since the polyadenylation site was not precisely determined. This exon contained 12 bp coding for 4 amino acid residues of the signal sequence, 336 bp coding for the entire mature protein (112 amino acid residues), and 160 bp of 3' non-coding sequence from the stop codon TAA through the poly A addition signal AATAAA to the poly A addition site. Another AATAAA was found at 89 bp downstream of the first poly A addition signal. The sizes of the first and the second intron were 1,259 and 4,473 bp, respectively. Both introns satisfied the GT-AG rule (14) and had sequences homologous to the consensus sequence YNYRAY (Y = pyrimidine, R = purine, N = any base) required for branching for splicing (15) about 30 bp upstream of the 3' end of each intron. The gene organization of PBI is summarized in Fig. 1 . The promoter sequence TATATAA (13) is found at 21-27 bp upstream of the putative transcriptional site. Another promoter sequence, CCAAT (16) , was present at 127-131 bp upstream of the transcriptional site as an inverse complementary form. When the region upstream of the transcriptional site was computer-searched for transcription factor-binding sites, a USF (upstream stimulatory factor) binding site was found at about 400 bp upstream. The TATA box, CCAAT box, and USF binding site are shown in Fig. 2 . GC boxes with a core consensus sequence GGGCGG, which have been shown to be present in several housekeeping genes (17), were not found.
Comparison of PBI Exons with P-B cDNA-Nucleotide sequence comparison of a combination of exons 1,2, and 3 of PBI with P-B cDNA by means of a Harr plot is shown in Fig. 3 . The result indicated that PBI is closely related to, but different from, P-B cDNA in terms of sequence. Here, we use the designation P-Bl for the gene product of PBI. A comparison of P-Bl precursor with P-B precursor is shown in Fig. 4 . P-Bl precursor was composed of 22 residues of signal sequence and 112 residues of mature protein sequence. The mature protein sequence was composed of 3 regions, i.e.,23 residues of N-terminal sequence, 5 prolinerich repeats of 13 to 14 residues, and 22 residues of C-terminal region. Each repeating unit usually starts with GPGXX' (X,X'*P) followed by a proline-rich peptide of several residues and ends with an aromatic amino acid. On the other hand, P-B precursor consists of 22 residues of signal sequence, 19 residues of N-terminal sequence, and 3 proline-rich repeats. The signal sequences and the Nterminal 16 residues of the precursors of P-Bl and P-B coincide completely. P-Bl is almost double the size of P-B. Homology Search-Computerized homology search of PBI with known sequences in a data base revealed that P-B cDNA had the highest score and rat VCS/91 gene (18) was next most homologous. VCSySl is the gene for the prolinerich protein PR-V/91 expressed in rat submaxillary gland. The gene organization of VCS/91 gene is very similar to that of PBI (IS). When the homology of the exons (exons 1-3) of PBI was searched in the data base, DNAs which gave the highest scores after P-B cDNA were those of proline-rich proteins MSGl of mouse (19) and PR-V/51 (28) of rat submaxillary glands. The amino acid sequences of MSGl and PR-V/91 are compared with those of P-Bl and P-B in Fig. 4 .
Expression of PBI-In the previous study (7), we performed Northern blot analysis of human heart, brain, placenta, lung, liver, skeletal muscle, kidney, and pancreas by using the P-B cDNA fragment as a probe and found that only placenta gave a hybridized band. The present result that the same P-B cDNA fragment was hybridizable with PBI is considered to indicate that the placenta could be the expression site of P-Bl. However, as the size of the positive mRNA (5-8 kb) (7) is much larger than the expected size of P-Bl mRNA (0.8 kb), the mRNA of the placenta is clearly different from P-Bl mRNA. Some mechanism may exist by which the precursor mRNA of placenta is processed to the shorter P-Bl mRNA. Since human submaxillary gland cDNA was hybridizable with the P-B cDNA fragment and since the size of the positive band was about 800 bp (7), the human submaxillary gland may express P-Bl together with P-B. To determine whether PB-1 is expressed in the submaxillary gland, PCR was performed by using oligonucleotides shared by both P-B and P-Bl cDNAs as primer pairs and human submaxillary gland cDNAs as a template, and EcoBI digests of the PCR products were analyzed electrophoretically. Bands corresponding to 393 and 56 bp were observed, but those corresponding to 200 and 282 bp were not. The former two bands were expected to be derived from cDNA coding for P-B, while the latter two were expected to be detected if cDNA coding for P-Bl was present in human submaxillary gland cDNAs. When human genomic DNA was used in place of human submaxillary gland cDNAs as the template in PCR, the expected two bands from P-B and those from PBI were all detected (Fig.  5 ). It appears that P-Bl is not expressed in the human submaxillary gland.
DISCUSSION
We have studied the P-B gene in order to elucidate its structure and to find out whether it belongs to a distinct gene family. The presence in bovine developing enamel of a proline-rich protein with an apparent molecular weight of 31,000, which is much larger than P-B (molecular weight 5,793), but whose amino-terminal 57 residues are identical with those of P-B (8), suggested that cloning might afford a gene different from the P-B gene. Indeed the gene isolated in the present work was not P-B gene itself but a homologous one. The putative translation product (P-Bl) of this newly isolated gene has a very high amino acid sequence homology with P-B. P-Bl is also different from the protein found in the bovine developing enamel having the 57 residues at the amino-terminal identical with those of P-B.
The nucleotide sequence homology and similarity in gene organization suggest that the rat gene family to which VCS/91 belongs (18) is the rat homolog of the human PBI gene family. This gene family may be ubiquitous among animal species, since Southern blot analysis using the P-B cDNA fragment as a probe revealed multiple positive signals in all the animals studied (7). It has been reported that P-B-related proteins of mice and rats are expressed in the salivary gland (18, 19) . Although human P-B is expressed in saliva (7) , P-Bl appears not to be expressed in the human submaxillary gland. Since PBI contains the nucleotide motifs required for transcription, splicing, translation, and polyadenylation (13) (14) (15) (16) , this gene could be expressed under specific conditions, such as mechanical and/or chemical stimulation in the oral cavity. Comparison of the PBI gene with the P-B gene, which actively produces P-B in the human adult submaxillary gland should provide clues to understand the difference in expression between these two genes. The P-B gene structure is under investigation.
Prohormone-like protein SMRl, the gene product of the gene VCSal, belonging to the rat homolog of the human PBI gene family, has the tetrapeptide Gln-His-Asn-Pro surrounded by two pairs of basic residues that represent potential processing sites. Peptides formed by digestion of SMRl at these sites were detected in rat saliva and blood (IS). Since PBI, like P-B, has no such sequence surrounded by two pairs of basic residues, these molecules may not be processed to produce hormone-like peptides.
